ARCHIVES

“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy

This article is from The Cancer Letter archive.

Vol. 19 No. 06 | February 5, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: Five Institutions To Test Interferon; Appendectomy-Cancer Association Noted

October 27, 1978

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013

NCI plans 11-16 percent budget cuts in new grants to maintain R01 payline at 20th percentile.

November 28, 2003

DCPC Board Will Consider Revised Concepts For CPRUs

September 18, 1987

BRCA1 and BRCA2 Mutations Linked To Higher Survival

January 27, 2012

NCCS Networker Volume 4 Issue 2, Spring 1990

April 13, 1990